July 12, 2013

Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

AAV patients with renal involvement who needed RRT had the worst survival probability. In multivariate analysis, the only major determinants for long-term renal survival were renal function at 6 months and renal relapses.

Me gusta

Guardar

Cite This Study

Joode et al. (Fri,) studied this question.

synapsesocial.com/papers/69dc623a98c6111533e52dab https://doi.org/https://doi.org/10.2215/cjn.01020113

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.1998 · 97 citations
2Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.1994 · 1,063 citations
3Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis2010 · 2,727 citations
4Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.1998 · 318 citations
5ANCA small-vessel vasculitis.1997 · 216 citations

Me gusta

Guardar